HYPR · Hyperfine, Inc.
$0.93
-0.05 (-5.19%)
At close · Jul 17
Market Cap
$92.39M
Shares
99,270,336
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.93
Open$0.98
Day$0.91–0.98
52W$0.84–2.22
Avg vol 30d1.4M
Short int3.4M · 3.4% float · 1.3d
Short vol41%
Last earningsMay 12, 2026
DataJan 2021–Jul 2026
Filing10-Q · May 12
Up next
Next earnings call
Aug 12, 2026
Est · unconfirmed
· in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.8 · elevated
Equity put/call 0.73
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−26%
below
Price vs 50-day avg
−35%
below
RSI (14)
26
oversold
MACD trend
Negative
52-week position
7%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−33%
trailing
6-month return
−25%
trailing
YTD return
−5%
this year
Relative strength
−33%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow
Flat
2 of 52 funds reported for Jun 30 · net 0 sh shares
Insider flow
Distributing
Net -$20.0K over 90 days · 100% sells
Short interest
Rising
3.38% of float · ▲ +98.1% MoM · 1.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
52 holders — near 3-yr high, broad support
Squeeze score
51
elevated · 0–100
Fundamentals
Revenue growth
+5%
Y/Y
Gross margin
50%
expanding
EPS growth
+23%
Y/Y
Free cash flow
$-29.1M
Balance sheet
$35.1M
net cash
Quant / Vol
risk profile
Volatility
91%
annualized · 1-yr
Max drawdown
−59%
past year
ATR
10.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 12, 2026
Revenue
· full year 2026
Initiated
$20M – $22M
prior FY $13.56M
midpoint +54.8% Y/Y
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−26%
Bearish
Price vs 50-day avg
−35%
Bearish
RSI (14)
26
Neutral
MACD trend
Negative
Bearish
52-week position
7%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow
Flat
2 of 52 funds reported for Jun 30 · net 0 sh shares
Insider flow
Distributing
Net -$20.0K over 90 days · 100% sells
Short interest
Rising
3.38% of float · ▲ +98.1% MoM · 1.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
52 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $1
Now $1 · 7%
52-wk high $2
vs 200-day avg -26%
vs 50-day avg -35%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| commercial Swoop® systems sold | 10 | first quarter of 2026 | — |
| gross margin | 50.7% | Q1 2026 call | — |
| net cash burn excluding financing | $8.8M | Q1 2026 call | — |
| units sold | 10 | Q1 2026 call | — |
| Swoop® systems sold (net) | 38 | FY2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HYPR
this stock
Hyperfine, Inc.
|
$92.39M | -4.9% | +5.2% | — | 3.4% |
|
ABT
Abbott Laboratories
|
$175.37B | -19.2% | +5.7% | 28.2 | 1.3% |
|
SYK
Stryker Corp
|
$122.63B | -8.7% | +11.2% | 37.0 | 1.8% |
|
MDT
Medtronic plc
|
$106.50B | -12.7% | +8.4% | 22.3 | 1.5% |
|
BSX
Boston Scientific Corp
|
$65.44B | -53.8% | +5.5% | 18.4 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HYPR | -14.6% | -33.0% | -24.9% | -31.0% | -4.9% |
| SPY | -1.5% | +0.3% | +7.8% | -0.5% | +9.0% |
| vs SPY | -13.1% | -33.3% | -32.8% | -30.6% | -13.9% |